Dysregulated palmitoylation of these proteins has been associated with diseases including schizophrenia, attention deficit hyperactivity disorder, and major depressive disorder [66, 67], supporting that similar impacts on DAT could contribute to imbalanced reuptake in DA disorders. The gene discussed is SLC6A3; the disease is schizophrenia.